EKF Diagnostics Holdings plc (AIM:EKF)

London flag London · Delayed Price · Currency is GBP · Price in GBX
27.50
-0.50 (-1.79%)
May 22, 2026, 4:35 PM GMT
Market Cap118.39M +29.1%
Revenue (ttm)51.56M +2.7%
Net Income2.12M -66.0%
EPS0.00 -65.8%
Shares Out430.50M
PE Ratio58.52
Forward PE16.76
Dividendn/a
Ex-Dividend Daten/a
Volume130,926
Average Volume231,044
Open26.60
Previous Close28.00
Day's Range26.50 - 27.90
52-Week Range21.80 - 32.00
Beta0.53
RSI60.77
Earnings DateJun 16, 2026

About EKF Diagnostics Holdings

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that provides a quantitative hematocrit reading for six blood samples. It also provides glucose and lactate analyzers, such as Biosen C-Line GP+ and C-Line Cl... [Read more]

Sector Healthcare
Founded 1990
Employees 297
Stock Exchange London Stock Exchange AIM
Ticker Symbol EKF
Full Company Profile

Financial Performance

In 2025, EKF Diagnostics Holdings's revenue was 51.56 million, an increase of 2.73% compared to the previous year's 50.19 million. Earnings were 2.12 million, a decrease of -66.00%.

Financial Statements

News

EKF Diagnostics Holdings Earnings Call Transcript: H2 2025

Revenue rose 3% to GBP 51.6m with gross margin up to 51% and EBITDA at GBP 12.4m. Strategic execution in 2025 included portfolio simplification, strong growth in LATAM and BHB, and a GBP 5m share buyback. Outlook targets operational excellence, new product launches, and continued expansion.

2 months ago - Transcripts

EKF Diagnostics Holdings Annual report: H2 2025

EKF Diagnostics Holdings has published its H2 2025 annual report on March 24, 2026.

2 months ago - Filings

EKF Diagnostics Holdings Slides: H2 2025

EKF Diagnostics Holdings has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 24, 2026.

2 months ago - Filings

EKF Diagnostics Holdings Earnings Call Transcript: H2 2025

Revenue rose 3% to GBP 51.6m with gross margin up to 51% and EBITDA at GBP 12.4m. Strategic execution in 2025 included portfolio simplification, strong growth in LATAM and BHB, and a GBP 5m share buyback. Outlook targets operational excellence, new product launches, and continued expansion.

2 months ago - Transcripts

EKF Diagnostics Holdings Annual report: H2 2025

EKF Diagnostics Holdings has published its H2 2025 annual report on March 24, 2026.

2 months ago - Filings

EKF Diagnostics Holdings Slides: H2 2025

EKF Diagnostics Holdings has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 24, 2026.

2 months ago - Filings

EKF Diagnostics Holdings Earnings Call Transcript: H2 2025

Revenue rose 3% to GBP 51.6m with gross margin up to 51% and EBITDA at GBP 12.4m. Strategic execution in 2025 included portfolio simplification, strong growth in LATAM and BHB, and a GBP 5m share buyback. Outlook targets operational excellence, new product launches, and continued expansion.

2 months ago - Transcripts

EKF Diagnostics Holdings Annual report: H2 2025

EKF Diagnostics Holdings has published its H2 2025 annual report on March 24, 2026.

2 months ago - Filings

EKF Diagnostics Holdings Slides: H2 2025

EKF Diagnostics Holdings has posted slides in relation to its H2 2025 quarterly earnings report, which was published on March 24, 2026.

2 months ago - Filings

EKF Diagnostics Holdings Earnings release: Q4 2025

EKF Diagnostics Holdings released its Q4 2025 earnings on January 27, 2026, summarizing the period's financial results.

4 months ago - Filings

EKF Diagnostics Holdings Earnings release: Q4 2025

EKF Diagnostics Holdings released its Q4 2025 earnings on January 27, 2026, summarizing the period's financial results.

4 months ago - Filings

EKF Diagnostics Holdings Earnings release: Q4 2025

EKF Diagnostics Holdings released its Q4 2025 earnings on January 27, 2026, summarizing the period's financial results.

4 months ago - Filings

EKF Diagnostics Holdings Earnings Call Transcript: H1 2025

Revenue and profit remained stable year-over-year, with gross margin improving to 50% and EBITDA up 7.4%. Strategic investments in production and Life Sciences, new contracts in growth markets, and a continued share buyback support long-term growth targets.

8 months ago - Transcripts

EKF Diagnostics Holdings Quarterly report: H1 2025

EKF Diagnostics Holdings has published its H1 2025 quarterly earnings report on September 16, 2025.

8 months ago - Filings

EKF Diagnostics Holdings Slides: H1 2025

EKF Diagnostics Holdings has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 16, 2025.

8 months ago - Filings

EKF Diagnostics Holdings Earnings Call Transcript: H1 2025

Revenue and profit remained stable year-over-year, with gross margin improving to 50% and EBITDA up 7.4%. Strategic investments in production and Life Sciences, new contracts in growth markets, and a continued share buyback support long-term growth targets.

8 months ago - Transcripts

EKF Diagnostics Holdings Quarterly report: H1 2025

EKF Diagnostics Holdings has published its H1 2025 quarterly earnings report on September 16, 2025.

8 months ago - Filings

EKF Diagnostics Holdings Slides: H1 2025

EKF Diagnostics Holdings has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 16, 2025.

8 months ago - Filings

EKF Diagnostics Holdings Earnings Call Transcript: H1 2025

Revenue and profit remained stable year-over-year, with gross margin improving to 50% and EBITDA up 7.4%. Strategic investments in production and Life Sciences, new contracts in growth markets, and a continued share buyback support long-term growth targets.

8 months ago - Transcripts

EKF Diagnostics Holdings Quarterly report: H1 2025

EKF Diagnostics Holdings has published its H1 2025 quarterly earnings report on September 16, 2025.

8 months ago - Filings

EKF Diagnostics Holdings Slides: H1 2025

EKF Diagnostics Holdings has posted slides in relation to its H1 2025 quarterly earnings report, which was published on September 16, 2025.

8 months ago - Filings

EKF Diagnostics Holdings Earnings release: Trading Update

EKF Diagnostics Holdings released its earnings on July 28, 2025, summarizing the period's financial results.

10 months ago - Filings

EKF Diagnostics Holdings Earnings release: Trading Update

EKF Diagnostics Holdings released its earnings on July 28, 2025, summarizing the period's financial results.

10 months ago - Filings

EKF Diagnostics Holdings Earnings release: Trading Update

EKF Diagnostics Holdings released its earnings on July 28, 2025, summarizing the period's financial results.

10 months ago - Filings